· Public charity
American Society for Pharmacology & Experimental Therapeutics Incorporated
The american society for pharmacology and experimental therapeutics (aspet) is a 4,000 member scientific society whose members conduct basic and clinical pharmacological research and work for academia, government, large pharmaceutical companies, small biotech companies, and non-profit organizations.
What it funded, over time
Every grant placed by its stated purpose and the recipient’s mission, by year, FY2017 to 2024.
Where the money goes
Grants by size, and the largest recipients.
| Recipient | Amount |
|---|---|
| UNIVERSITY OF ARKANSAS | $55,200 |
| WASHINGTON STATE UNIVERSITY | $55,200 |
| UTHSCSA | $55,200 |
| LSU HEALTH SHREVEPORT | $55,200 |
| PACIFIC UNIVERSITY | $55,200 |
Does the money reach high-need areas?
Each grant placed by the hardship in its grantee’s ZIP, against the area’s typical level.
Dollar for dollar, its grants (FY17–24) land where the poverty rate runs at 13%, against an area that typically sits at 10%. 85% of its dollars go to grantees based in above-average-need neighborhoods. Most of its grants land in higher-need ZIPs.
How this is measured
Which US states its grants reach
How this is measured
Where the work is directed
The same grants placed two ways: where each recipient sits, and where its stated purpose sends the money.
About 9% of American Society for Pharmacology & Experimental Therapeutics Incorporated’s grant dollars are earmarked for a different county than the recipient’s own address.
How this is measured
Who it funds again
Organizations funded in more than one year, against those funded once.
Grantees it renews have grown median revenue +51% since the first grant, against +39% for those funded once.
21 repeat relationships: 4 still active in FY2024, 17 since wound down; 1 grantees were first funded in FY2024 (too recent to call).
How the two cohorts compare
Organizations
Total granted
Median revenue growth · since first grant
Still filing today
New vs renewed · share of each year
In FY2024, 80% of grant dollars renewed an existing relationship; $55k went to new ones.
How this is measured
Backed again, and grew
DUKE UNIVERSITY7× · 2017–2023 · $66k · revenue +51%- PUPACIFIC UNIVERSITY4× · 2019–2024 · $64k · revenue +7%
- TRThe Research Foundation for The State University of New York7× · 2017–2023 · $45k · revenue +62%
Funded once
- UOUNIVERSITY OF TEXASone grant, 2020 · $100k
- LULOYOLA UNIVERSITY OF CHICAGOgraduatedone grant, 2017 · $9k · revenue +39%
- SUSTATE UNIVERSITY OF NEW YORK AT BINGHAMTONone grant, 2017 · $9k
How this is measured
Repeat means funded in two or more distinct years. Growth and survival are read from each grantee’s own subsequent IRS filings.
7 grantees tracked through their own filings, 2017–2025.
Each grant beside the grantee’s revenue from every source, year by year.
How this is measured
Counted here: distinct organizations funded across 2017 to 2025, not grant rows in a single year, so this will not match the grant count on the cover. 7 of the 25 grantees resolved in that span have returns of their own we could reconcile.
Each grantee is resolved to its own IRS returns. Association, dated; never a causal claim.
Where the money sits, by cause and then by grantee
Each grantee by its size and the funder’s share of it; top left is load-bearing
Grantee by grantee: a decade per organization, before and after funding
A decade per grantee: revenue shaded, grants as bars, all rows on one timeline.
How much its grantees rely on government
Each dot is one organization American Society for Pharmacology & Experimental Therapeutics Incorporated funds: left to right is the share of its income from government, bottom to top the share from American Society for Pharmacology & Experimental Therapeutics Incorporated. Bigger dots raise more.
- Pacific University: 5% of income from government
How this is measured
Play a game based on American Society for Pharmacology & Experimental Therapeutics’ filings →